Spineway Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	12.43	11.95	10.52	7.43	4.86
Other Revenue	-	0.78	0.84	1.22	0.17
Revenue	12.43	12.73	11.36	8.65	5.04
Revenue Growth (YoY)	-2.38%	12.11%	31.34%	71.76%	11.59%
Cost of Revenue	3.78	7.39	8.89	6.02	3.34
Gross Profit	8.65	5.34	2.46	2.63	1.7
Selling, General & Admin	10.78	4.89	5.73	4.88	2.48
Other Operating Expenses	-	0.4	0.39	0.4	-0.26
Operating Expenses	10.78	6.23	6.98	5.84	3.11
Operating Income	-2.13	-0.89	-4.52	-3.21	-1.41
Interest Expense	-0.32	-	-	-	-0.05
Currency Exchange Gain (Loss)	-	-0	-0.01	-0.01	-0.01
Other Non Operating Income (Expenses)	-	-2.46	-1.03	0.19	0.28
EBT Excluding Unusual Items	-2.45	-3.35	-5.55	-3.03	-1.19
Other Unusual Items	0.06	-0.51	-0.96	-0.11	-0.4
Pretax Income	-2.39	-3.87	-6.51	-3.14	-1.58
Income Tax Expense	-0.15	-	-	-	-
Net Income	-2.24	-3.87	-6.51	-3.14	-1.58
Net Income to Common	-2.24	-3.87	-6.51	-3.14	-1.58
Shares Outstanding (Basic)	-	-	16	-	-
Shares Outstanding (Diluted)	-	-	16	-	-
EPS (Basic)	-	-	-0.41	-	-
EPS (Diluted)	-	-	-0.41	-	-
Free Cash Flow	-	-3.27	-6.37	-13.89	-2.88
Free Cash Flow Per Share	-	-	-0.40	-	-
Gross Margin	69.57%	41.96%	21.69%	30.40%	33.68%
Operating Margin	-17.16%	-6.95%	-39.76%	-37.12%	-28.00%
Profit Margin	-18.00%	-30.35%	-57.32%	-36.27%	-31.46%
Free Cash Flow Margin	-	-25.71%	-56.12%	-160.65%	-57.20%
EBITDA	-1.42	-0.18	-3.66	-3	-1.29
EBITDA Margin	-11.46%	-1.38%	-32.20%	-34.74%	-25.64%
D&A For EBITDA	0.71	0.71	0.86	0.21	0.12
EBIT	-2.13	-0.89	-4.52	-3.21	-1.41
EBIT Margin	-17.16%	-6.95%	-39.76%	-37.12%	-28.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.